270 related articles for article (PubMed ID: 23935463)
1. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
2. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
Michels KA; Pfeiffer RM; Brinton LA; Trabert B
JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and risk of ovarian cancer.
Leitzmann MF; Koebnick C; Danforth KN; Brinton LA; Moore SC; Hollenbeck AR; Schatzkin A; Lacey JV
Cancer; 2009 Feb; 115(4):812-22. PubMed ID: 19127552
[TBL] [Abstract][Full Text] [Related]
4. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.
Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
Aust N Z J Public Health; 2015 Oct; 39(5):434-40. PubMed ID: 26437728
[TBL] [Abstract][Full Text] [Related]
5. A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers.
Wilson KM; Mucci LA; Rosner BA; Willett WC
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2503-15. PubMed ID: 20693310
[TBL] [Abstract][Full Text] [Related]
6. Dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal women: a prospective cohort study.
Eriksen KT; Halkjær J; Sørensen M; Meliker JR; McElroy JA; Tjønneland A; Raaschou-Nielsen O
PLoS One; 2014; 9(6):e100815. PubMed ID: 24963789
[TBL] [Abstract][Full Text] [Related]
7. An epidemiological model for prediction of endometrial cancer risk in Europe.
Hüsing A; Dossus L; Ferrari P; Tjønneland A; Hansen L; Fagherazzi G; Baglietto L; Schock H; Chang-Claude J; Boeing H; Steffen A; Trichopoulou A; Bamia C; Katsoulis M; Krogh V; Palli D; Panico S; Onland-Moret NC; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Gram IT; Ardanaz E; Obón-Santacana M; Navarro C; Sánchez-Cantalejo E; Etxezarreta N; Allen NE; Khaw KT; Wareham N; Rinaldi S; Romieu I; Merritt MA; Gunter M; Riboli E; Kaaks R
Eur J Epidemiol; 2016 Jan; 31(1):51-60. PubMed ID: 25968175
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Maas P; Barrdahl M; Joshi AD; Auer PL; Gaudet MM; Milne RL; Schumacher FR; Anderson WF; Check D; Chattopadhyay S; Baglietto L; Berg CD; Chanock SJ; Cox DG; Figueroa JD; Gail MH; Graubard BI; Haiman CA; Hankinson SE; Hoover RN; Isaacs C; Kolonel LN; Le Marchand L; Lee IM; Lindström S; Overvad K; Romieu I; Sanchez MJ; Southey MC; Stram DO; Tumino R; VanderWeele TJ; Willett WC; Zhang S; Buring JE; Canzian F; Gapstur SM; Henderson BE; Hunter DJ; Giles GG; Prentice RL; Ziegler RG; Kraft P; Garcia-Closas M; Chatterjee N
JAMA Oncol; 2016 Oct; 2(10):1295-1302. PubMed ID: 27228256
[TBL] [Abstract][Full Text] [Related]
9. Dietary acrylamide intake and the risk of endometrial or ovarian cancers in Japanese women.
Kotemori A; Ishihara J; Zha L; Liu R; Sawada N; Iwasaki M; Sobue T; Tsugane S;
Cancer Sci; 2018 Oct; 109(10):3316-3325. PubMed ID: 30063274
[TBL] [Abstract][Full Text] [Related]
10. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.
Bernatsky S; Ramsey-Goldman R; Foulkes WD; Gordon C; Clarke AE
Br J Cancer; 2011 Apr; 104(9):1478-81. PubMed ID: 21487409
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for developing multiple malignancies in patients with endometrial cancer.
Uccella S; Cha SS; Melton LJ; Bergstralh EJ; Boardman LA; Keeney GL; Podratz KC; Ciancio FF; Mariani A
Int J Gynecol Cancer; 2011 Jul; 21(5):896-901. PubMed ID: 21666488
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of a breast cancer absolute risk prediction model in Chinese population.
Han Y; Lv J; Yu C; Guo Y; Bian Z; Hu Y; Yang L; Chen Y; Du H; Zhao F; Wen W; Shu XO; Xiang Y; Gao YT; Zheng W; Guo H; Liang P; Chen J; Chen Z; Huo D; Li L;
Breast Cancer Res; 2021 May; 23(1):62. PubMed ID: 34051827
[TBL] [Abstract][Full Text] [Related]
13. Predicting risk of endometrial cancer in asymptomatic women (PRECISION): Model development and external validation.
Kitson SJ; Crosbie EJ; Evans DG; Lophatananon A; Muir KR; Ashcroft D; Kontopantelis E; Martin GP
BJOG; 2024 Jun; 131(7):996-1005. PubMed ID: 38073256
[TBL] [Abstract][Full Text] [Related]
14. Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study.
Fournier A; Cairat M; Severi G; Gunter MJ; Rinaldi S; Dossus L
J Natl Cancer Inst; 2023 Jun; 115(6):671-679. PubMed ID: 36809347
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
Jones ME; Schoemaker MJ; Wright L; McFadden E; Griffin J; Thomas D; Hemming J; Wright K; Ashworth A; Swerdlow AJ
Br J Cancer; 2016 Aug; 115(5):607-15. PubMed ID: 27467055
[TBL] [Abstract][Full Text] [Related]
16. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.
Reeves GK; Pirie K; Beral V; Green J; Spencer E; Bull D;
BMJ; 2007 Dec; 335(7630):1134. PubMed ID: 17986716
[TBL] [Abstract][Full Text] [Related]
17. An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.
Li K; Hüsing A; Fortner RT; Tjønneland A; Hansen L; Dossus L; Chang-Claude J; Bergmann M; Steffen A; Bamia C; Trichopoulos D; Trichopoulou A; Palli D; Mattiello A; Agnoli C; Tumino R; Onland-Moret NC; Peeters PH; Bueno-de-Mesquita HB; Gram IT; Weiderpass E; Sánchez-Cantalejo E; Chirlaque MD; Duell EJ; Ardanaz E; Idahl A; Lundin E; Khaw KT; Travis RC; Merritt MA; Gunter MJ; Riboli E; Ferrari P; Terry K; Cramer D; Kaaks R
Br J Cancer; 2015 Mar; 112(7):1257-65. PubMed ID: 25742479
[TBL] [Abstract][Full Text] [Related]
18. A model for predicting both breast cancer risk and non-breast cancer death among women > 55 years old.
Schonberg MA; Wolfson EA; Eliassen AH; Bertrand KA; Shvetsov YB; Rosner BA; Palmer JR; Ngo LH
Breast Cancer Res; 2023 Jan; 25(1):8. PubMed ID: 36694222
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK
Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545
[TBL] [Abstract][Full Text] [Related]
20. Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic.
Birmann BM; Barnard ME; Bertrand KA; Bao Y; Crous-Bou M; Wolpin BM; De Vivo I; Tworoger SS
Am J Public Health; 2016 Sep; 106(9):1608-15. PubMed ID: 27459458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
